Pacific Biosciences of California, Inc. Effective Income Tax Rate Reconciliation, Tax Contingency, Amount
Pacific Biosciences of California, Inc. (PACB) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Amount of $1.55 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxContingencies · last filed 2026-02-25
- Pacific Biosciences of California, Inc. effective income tax rate reconciliation, tax contingency, amount for fiscal 2025 was $1.55M, a 50.45% decline from fiscal 2024.
- Pacific Biosciences of California, Inc. effective income tax rate reconciliation, tax contingency, amount for fiscal 2024 was $3.12M, a 49.02% increase from fiscal 2023.
- Pacific Biosciences of California, Inc. effective income tax rate reconciliation, tax contingency, amount for fiscal 2023 was $2.10M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 12 month |
|---|---|
| 2025-12-31 | $1.55M 10-K · filed 2026-02-25 |
| 2024-12-31 | $3.12M 10-K · filed 2026-02-25 |
| 2023-12-31 | $2.10M 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |